L Catterton, a leading consumer investment firm, has agreed to sell Thorne, a science-backed wellness brand, to Procter & Gamble for $3.8 billion in cash. Since investing in Thorne in 2023, L Catterton accelerated its growth by enhancing leadership, marketing, R&D, and technology, solidifying Thorne's position in the wellness market. The deal highlights the rising consumer demand for clinically-backed health products and is expected to close in Q4 2026. This acquisition will allow Procter & Gamble to expand its presence in the health and wellness sector.
Procter & Gamble, Johnson & Johnson, and Coca-Cola are set to reach target prices of $180, $300, and $100 respectively by 2027, driven by their strong dividend histories and growth catalysts. PG aims for $180 supported by productivity gains and stead...
Procter & Gamble (P&G) has agreed to acquire Thorne, a leader in science-backed health and wellness solutions, to strengthen its position in the premium wellness market. Thorne, trusted by healthcare practitioners and consumers since 1984, offers hig...
